Drawing for LYOMICTRA

USPTO serial 79382550

LYOMICTRA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BURRUS, JESSICA E
Law office
TMO LAW OFFICE 121

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with LYOMICTRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Biological agents (bacterial, fungal or other fungicides, weedkillers, herbicides, insecticides, parasiticides, pesticides); biological control agents; biological preparations for medical purposes; biological preparations for pharmaceutical purposes; biological preparations for use in biotechnology (medical); biological preparations for use in cell cultures (medical); biological products for medical use; biological substances for medical use; biological tissue cultures for medical purposes; reagents for use in biological processing (for medical purposes); bacteriological culture mediums; bacteriological cultures for medical and veterinary use; bacteriological preparations for medical and veterinary use; testing reagents for medical use in detecting allergenic substances; capsules for pharmaceutical purposesACTIVE—
042Biological research; bacteriological research; biotechnology testing; biochemistry research services; biotechnology research; research relating to biotechnology; biotechnological research; genetic research; medical research; preparation of reports relating to technical research; conducting statistical scientific studies; pharmaceutical research services; rental of research facilities; research and development of new products for others; research to develop new products; research relating to bacteriology; advisory services relating to technological research; technological research; provision of scientific information; advisory services relating to scientific research; medical research (scientific research for medical purposes); preparation of reports relating to scientific research; analysis of statistical data for scientific research; scientific research into the development of new products; scientific research relating to bacteriology; scientific research relating to biology; scientific research relating to genetics; providing information, including online, about scientific and technological services and research and design relating thereto; provision of information relating to scientific research; scientific researchACTIVE—
044Advisory services relating to medical services; alternative medical services; providing medical services for charitable purposes; gastroenterology (medical services); medical diagnostic services (testing and analysis); advisory services relating to medical problemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 22, 2026FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 2, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 2, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 28, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 19, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 31, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 31, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 2, 2025MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 2, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 30, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 8, 2024RFNTREFUSAL PROCESSED BY IB—
Jun 17, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 17, 2024RFRRREFUSAL PROCESSED BY MPU—
Jun 5, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 5, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 17, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2024DOCKASSIGNED TO EXAMINER—
Nov 11, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 7, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance